换一批
换一批Assessment of the anti-CD40 antibody iscalimab in patients with primary Sjögren's syndrome: a multicentre, randomised, double-blind, placebo-controlled, proof-of-concept study.
作者：
Benjamin A,Fisher [1]
;
Antonia,Szanto [2]
;
Wan-Fai,Ng [3]
;
Michele,Bombardieri [4]
;
Maximilian G,Posch [5]
;
Athena S,Papas [6]
;
Arwa M,Farag [7]
;
Thomas,Daikeler [8]
;
Bettina,Bannert [8]
;
Diego,Kyburz [8]
;
Alan J,Kivitz [9]
;
Steven E,Carsons [10]
;
David A,Isenberg [11]
;
Francesca,Barone [1]
;
Simon J,Bowman [1]
;
Pascal,Espié [12]
;
David,Floch [12]
;
Cyrielle,Dupuy [12]
;
Xiaohui,Ren [12]
;
Petra M,Faerber [12]
;
Andrew M,Wright [13]
;
Hans-Ulrich,Hockey [14]
;
Michael,Rotte [12]
;
Julie,Milojevic [12]
;
Alexandre,Avrameas [12]
;
Marie-Anne,Valentin [12]
;
James S,Rush [12]
;
Peter,Gergely [15]
作者单位：
National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre and Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK; Rheumatology Department, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
[1]
Division of Clinical Immunology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary.
[2]
NIHR Newcastle Biomedical Research Centre and Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK; Clinical Research Facility, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
[3]
William Harvey Research Institute, Queen Mary University of London, London, UK.
[4]
Charité Research Organisation, Berlin, Germany.
[5]
Division of Oral Medicine, Tufts University School of Dental Medicine, Tufts University, Boston, USA.
[6]
Division of Oral Medicine, Tufts University School of Dental Medicine, Tufts University, Boston, USA; Department of Oral Diagnostic Science, Faculty of Dentistry, King AbdulAziz University, Jeddah, Saudi Arabia.
[7]
Department of Rheumatology, University Hospital Basel, Basel, Switzerland.
[8]
Department of Rheumatology, Altoona Center for Clinical Research, Duncansville, PA, USA.
[9]
Division of Rheumatology, Allergy and Immunology NYU Winthrop Hospital, NYU Long Island School of Medicine, New York, NY, USA.
[10]
Centre for Rheumatology, Department of Medicine, University College London Hospital, London, UK.
[11]
Novartis Institutes for Biomedical Research, Basel, Switzerland.
[12]
Novartis Pharma, Basel, Switzerland.
[13]
Biometrics Matters, Hamilton, New Zealand.
[14]
Novartis Institutes for Biomedical Research, Basel, Switzerland. Electronic address: peter.gergely@novartis.com.
[15]
DOI
10.1016/S2665-9913(19)30135-3
PMID
38263652
发布时间
2024-05-29
- 浏览0
The Lancet. Rheumatology
The Lancet. Rheumatology
2020年2卷3期
e142-e152页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
